Comprehensive Psychiatry
Volume 51, Issue 3 , Pages 312-318 , May 2010

The significance of anabolic androgenic steroids in a Swedish prison population

  • Fia Klötz

      Affiliations

    • Department of Surgical Sciences, Forensic Medicine, Uppsala University, SE-752 37 Uppsala, Sweden
    • Corresponding Author InformationCorresponding author.
    • ,
  • Anna Petersson

      Affiliations

    • Department of Surgical Sciences, Forensic Medicine, Uppsala University, SE-752 37 Uppsala, Sweden
    • ,
  • Orsolya Hoffman

      Affiliations

    • Centre for Substance Abuse, Eskilstuna Hospital, SE-631 88 Eskilstuna, Stockholm, Sweden
    • National Swedish Prisons and Probation Administration, Stockholm Region, SE-102 23 Stockholm, Sweden
    • ,
  • Ingemar Thiblin

      Affiliations

    • Department of Surgical Sciences, Forensic Medicine, Uppsala University, SE-752 37 Uppsala, Sweden

References 

  1. Marshall E. The drug of champions. Science. 1988;242(4876):183–184
  2. Corrigan B. Anabolic steroids and the mind. Med J Aust. 1996;165(4):222–226
  3. Wichstrom L, Pedersen W. Use of anabolic-androgenic steroids in adolescence: winning, looking good or being bad?. J Stud Alcohol. 2001;62(1):5–13
  4. Tanner SM, Miller DW, Alongi C. Anabolic steroid use by adolescents: prevalence, motives, and knowledge of risks. Clin J Sport Med. 1995;5(2):108–115
  5. Thiblin I, Petersson A. Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol. 2005;19(1):27–44
  6. Pallesen S, Josendal O, Johnsen BH, Larsen S, Molde H. Anabolic steroid use in high school students. Subst Use Misuse. 2006;41(13):1705–1717
  7. McCabe SE, Brower KJ, West BT, Nelson TF, Wechsler H. Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys. Drug Alcohol Depend. 2007;90(2-3):243–251
  8. Wanjek B, Rosendahl J, Strauss B, Gabriel HH. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes. Int J Sports Med. 2007;28(4):346–353
  9. Dodge TL, Jaccard JJ. The effect of high school sports participation on the use of performance-enhancing substances in young adulthood. J Adolesc Health. 2006;39(3):367–373
  10. Kindlundh AM, Hagekull B, Isacson DG, Nyberg F. Adolescent use of anabolic-androgenic steroids and relations to self-reports of social, personality and health aspects. Eur J Public Health. 2001;11(3):322–328
  11. Nilsson S, Spak F, Marklund B, Baigi A, Allebeck P. Attitudes and behaviors with regards to androgenic anabolic steroids among male adolescents in a county of Sweden. Subst Use Misuse. 2005;40(1):1–12
  12. Brower KJ, Blow FC, Beresford TP, Fuelling C. Anabolic-Androgenic steroid dependence. J Clin Psychiatry. 1989;50(1):31–33
  13. Brower KJ, Catlin DH, Blow FC, Eliopulos GA, Beresford TP. Clinical assessment and urine testing for anabolic-androgenic steroid abuse and dependence. Am J Drug Alcohol Abuse. 1991;17(2):161–171
  14. Brower KJ, Eliopulos GA, Blow FC, Catlin DH, Beresford TP. Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters. Am J Psychiatry. 1990;147(4):510–512
  15. Copeland J, Peters R, Dillon P. Anabolic-Androgenic steroid use disorders among a sample of Australian competitive and recreational users. Drug Alcohol Depend. 2000;60(1):91–96
  16. Su TP, Pagliaro M, Schmidt PJ, Pickar D, Wolkowitz O, Rubinow DR. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA. 1993;269(21):2760–2764
  17. Daly RC, Su TP, Schmidt PJ, Pagliaro M, Pickar D, Rubinow DR. Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers. Psychoneuroendocrinology. 2003;28(3):317–331
  18. Freinhar JP, Alvarez W. Androgen-induced hypomania. J Clin Psychiatry. 1985;46(8):354–355
  19. Pope HG, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry. 1994;51(5):375–382
  20. Allnutt S, Chaimowitz G. Anabolic-steroid withdrawal depression—a case report. Can J Psychiatry-Revue Canadienne De Psychiatrie. 1994;39(5):317–318
  21. Elofson G, Elofson S. Steroids claimed our sons life. Phys Sportsmed. 1990;18(8):15–16
  22. Parssinen M, Kujala U, Vartiainen E, Sarna S, Seppala T. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med. 2000;21(3):225–227
  23. Thiblin I, Lindquist O, Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci. 2000;45(1):16–23
  24. Kouri EM, Lukas SE, Pope HG, Oliva PS. Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug Alcohol Depend. 1995;40(1):73–79
  25. Conacher GN, Workman DG. Violent crime possibly associated with anabolic steroid use. Am J Psychiatry. 1989;146(5):679
  26. Schulte HM, Hall MJ, Boyer M. Domestic violence associated with anabolic steroid abuse. Am J Psychiatry. 1993;150(2):348
  27. Thiblin I, Kristiansson R, Rajs J. Anabolic androgenic steroids and behavioural patterns among violent offenders. J Forensic Psychiatr. 1997;8(2):299–310
  28. Thiblin I, Parlklo T. Anabolic androgenic steroids and violence. Acta Psychiatr Scand Suppl. 2002;(412):125–128
  29. Pope HG, Katz DL. Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry. 1990;51(1):28–31
  30. Pope HG, Kouri EM, Powell KF, Campbell C, Katz DL. Anabolic-Androgenic steroid use among 133 prisoners. Compr Psychiatry. 1996;37(5):322–327
  31. Isacsson G, Garle M, Ljung EB, Asgard U, Bergman U. Anabolic steroids and violent crime—an epidemiological study at a jail in Stockholm, Sweden. Compr Psychiatry. 1998;39(4):203–205
  32. Klotz F, Garle M, Granath F, Thiblin I. Criminality among individuals testing positive for the presence of anabolic androgenic steroids. Arch Gen Psychiatry. 2006;63(11):1274–1279
  33. Klotz F, Petersson A, Isacson D, Thiblin I. Violent crime and substance abuse: a medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugs. Forensic Sci Int. 2007;173(1):57–63
  34. McLellan AT, Luborsky L, Woody GE, Obrien CP. Improved diagnostic evaluation instrument for substance abuse patients—Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26–33
  35. Andréasson S, Lindström U, Armelius B-Å, Larsson H, Berglund M, Frank A, et al. ASI—En Strukturerad Intervjumetod För Bedömning Av Alkohol- Och Narkotikarelaterade Problem. Stockholm: Centrum för utvärdering av socialt arbete; 1999;
  36. Kyle UG, Schutz Y, Dupertuis YM, Pichard C. Body composition interpretation. Contributions of the fat-free mass index and the body fat mass index. Nutrition. 2003;19(7-8):597–604
  37. Trenton AJ, Currier GW. Behavioural manifestations of anabolic steroid use. CNS Drugs. 2005;19(7):571–595
  38. Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction. 2006;101(2):181–191
  39. Fazel S, Danesh J. Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys. Lancet. 2002;359(9306):545–550
  40. Carey KB, Cocco KM, Simons JS. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients. Psychiatr Serv. 1996;47(8):842–847
  41. Gerevich J, Bacskai E, Ko J, Rozsa S. Reliability and validity of the Hungarian version of the European Addiction Severity Index. Psychopathology. 2005;38(6):301–309
  42. Scheurich A, Muller MJ, Wetzel H, Anghelescu I, Klawe C, Ruppe A, et al. Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). J Stud Alcohol. 2000;61(6):916–919
  43. Senoo E, Ogai Y, Haraguchi A, Kondo A, Ishibashi Y, Umeno M, et al. Reliability and validity of the Japanese version of the Addiction Severity Index (ASI-J). Nihon Arukoru Yakubutsu Igakkai Zasshi. 2006;41(4):368–379
  44. Langeland W, Draijer N, van den Brink W. Assessment of lifetime physical and sexual abuse in treated alcoholics. Validity of the Addiction Severity Index. Addict Behav. 2003;28(5):871–881
  45. Hall RC, Chapman MJ. Psychiatric complications of anabolic steroid abuse. Psychosomatics. 2005;46(4):285–290
  46. Choi PY, Parrott AC, Cowan D. High-dose anabolic steroids in strength athletes: effects upon hostility and aggression. Hum Psychopfarmacol. 1990;5:349–356
  47. Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand. 2000;78(2):146–153

PII: S0010-440X(09)00070-4

doi: 10.1016/j.comppsych.2009.05.007

Comprehensive Psychiatry
Volume 51, Issue 3 , Pages 312-318 , May 2010

Article Tools